Oppenheimer Cuts Integral Ad Science (NASDAQ:IAS) Price Target to $18.00

Integral Ad Science (NASDAQ:IAS) had its price target cut by Oppenheimer from $20.00 to $18.00 in a research note released on Wednesday morning,Benzinga reports. The firm currently has an outperform rating on the stock.

Several other brokerages also recently issued reports on IAS. Benchmark reaffirmed a “hold” rating on shares of Integral Ad Science in a research report on Monday, August 5th. Raymond James boosted their price target on shares of Integral Ad Science from $13.00 to $15.00 and gave the stock an “outperform” rating in a research report on Friday, August 2nd. Barclays upped their price target on shares of Integral Ad Science from $12.00 to $13.00 and gave the company an “equal weight” rating in a research note on Monday, August 5th. Finally, Morgan Stanley increased their price objective on shares of Integral Ad Science from $12.00 to $13.00 and gave the company an “equal weight” rating in a research note on Tuesday, July 23rd. Three research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. According to MarketBeat, Integral Ad Science currently has an average rating of “Moderate Buy” and a consensus target price of $15.70.

Integral Ad Science Trading Down 6.1 %

Shares of IAS stock opened at $10.11 on Wednesday. The company has a debt-to-equity ratio of 0.07, a current ratio of 3.71 and a quick ratio of 3.76. The business’s fifty day moving average price is $11.09 and its 200 day moving average price is $10.47. Integral Ad Science has a 1-year low of $7.98 and a 1-year high of $17.53. The firm has a market capitalization of $1.64 billion, a PE ratio of 50.55, a P/E/G ratio of 1.46 and a beta of 1.52.

Integral Ad Science (NASDAQ:IAS) last released its quarterly earnings results on Tuesday, November 12th. The company reported $0.10 earnings per share for the quarter, beating analysts’ consensus estimates of $0.08 by $0.02. Integral Ad Science had a net margin of 6.39% and a return on equity of 3.47%. The business had revenue of $133.50 million during the quarter, compared to analyst estimates of $138.06 million. During the same period last year, the business earned ($0.09) EPS. The business’s revenue was up 11.0% on a year-over-year basis. As a group, sell-side analysts forecast that Integral Ad Science will post 0.25 EPS for the current fiscal year.

Insider Activity at Integral Ad Science

In related news, CEO Lisa Utzschneider sold 10,481 shares of the business’s stock in a transaction on Monday, October 7th. The shares were sold at an average price of $10.11, for a total transaction of $105,962.91. Following the transaction, the chief executive officer now owns 239,709 shares in the company, valued at $2,423,457.99. The trade was a 4.19 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Tania Secor sold 5,240 shares of the business’s stock in a transaction dated Monday, October 7th. The stock was sold at an average price of $10.11, for a total transaction of $52,976.40. Following the completion of the transaction, the chief financial officer now directly owns 248,223 shares in the company, valued at $2,509,534.53. This trade represents a 2.07 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 23,006 shares of company stock valued at $240,296 over the last quarter. 2.00% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the company. Vanguard Group Inc. lifted its holdings in shares of Integral Ad Science by 7.0% in the 1st quarter. Vanguard Group Inc. now owns 8,673,229 shares of the company’s stock worth $86,472,000 after buying an additional 566,982 shares during the period. Clearbridge Investments LLC increased its holdings in shares of Integral Ad Science by 11.8% in the first quarter. Clearbridge Investments LLC now owns 3,906,652 shares of the company’s stock valued at $38,949,000 after purchasing an additional 412,044 shares during the last quarter. TimesSquare Capital Management LLC increased its stake in Integral Ad Science by 0.6% during the third quarter. TimesSquare Capital Management LLC now owns 2,772,440 shares of the company’s stock worth $29,970,000 after acquiring an additional 17,166 shares during the last quarter. abrdn plc boosted its holdings in Integral Ad Science by 12.5% in the third quarter. abrdn plc now owns 2,147,656 shares of the company’s stock valued at $23,216,000 after purchasing an additional 237,930 shares during the period. Finally, Geode Capital Management LLC increased its position in shares of Integral Ad Science by 6.4% during the third quarter. Geode Capital Management LLC now owns 1,834,659 shares of the company’s stock worth $19,836,000 after purchasing an additional 110,149 shares in the last quarter. 95.78% of the stock is owned by hedge funds and other institutional investors.

Integral Ad Science Company Profile

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.